Weight-loss wars: $10bn hostile battle pits Pfizer against Novo Nordisk ⊖⊖
Two groups fight for edge in one of the most lucrative drug classes in pharmaceutical industry history
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.